- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01012505
The Effect of Exposure to Maternal Human Milk Odor on Physiological State of Preterms.
Mammalian fetal sensory development comes in an invariant series, with the tactile/kinesthetic and chemosensory systems the earliest functioning and responsive to stimulation, implicating the importance of these foundational sensory systems for later development. Olfaction is essential for neonatal behavioral adaptation in many mammals, including humans. Experiments show that newborns recognize, and are soothed by, the smell of amniotic fluid. Provision of the mother's smell with breast pads, handkerchiefs she has worn, breast milk on a cotton ball or cotton applicator, or other means of providing odor and taste input can facilitate recognition by the infant's mother at a later time and does not appear to be detrimental to the stability of the infant.
Provision of the odor and taste of the mother's milk has been shown to facilitate the infant's mouthing, sucking, arousal, and calming from irritability, especially in preparation for oral feeding. Using 24 hour monitor analysis and cortisol saliva measurements, we will provide quantitive analysis to the effect of smell.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Ramat - Gan, Israel, 52621
- Sheba Medical Center
-
Contact:
- Ayala Maayan-Metzger, Dr.
- Phone Number: 972-3-5302227
- Email: maayan@post.tau.ac.il
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- preterm infants at least 1 week of age
- no active disease or treatment (like respiratory support)
- place in incubator
Exclusion Criteria:
- active disease or treatment
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
20 preterm infants
20 preterm infants without active disease
|
2 days prior to intervention - recording infants data and taking saliva cortisol adding pad with maternal milk - during 2 days - recording infants data and taking saliva cortisol. stopping intervention and for other 2 days recording infants data and taking saliva cortisol |
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHEBA-09-7392-AM-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health Preterm Infants With no Active Disease
-
Hadassah Medical OrganizationWithdrawnPreterm Infants With White Matter Damage | Preterm Infants Developing Normally
-
THIM - die internationale Hochschule für PhysiotherapieVrije Universiteit BrusselCompletedHealthy Volunteers | Persons With no Known Significant Health ProblemsSwitzerland
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal DiseasesUnited States
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal DiseasesUnited States
-
University of the State of Santa CatarinaCompletedRespiratory Therapy | Infants With Heart Disease | TechniquesBrazil
-
Vapotherm, Inc.Oxford University Hospitals NHS Trust; Ashford and St. Peter's Hospitals NHS...CompletedOxygen Titration in Preterm Infants to Manage Lung DiseaseUnited Kingdom
-
Louisiana State University Health Sciences Center...TerminatedPreterm Infants | Metabolic Bone DiseaseUnited States
-
KU LeuvenRecruitingHealthy Controls | IBS | Ulcerative Colitis, Active | Ulcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms) | Crohn's Disease, Active | Crohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)Belgium
-
Mansoura UniversityCompletedPreterm Infants | Respiratory Distress Syndrome | Premature Infants | Hyaline Membrane DiseaseEgypt
-
University of SurreyThe Leeds Teaching Hospitals NHS Trust; University Hospital Birmingham NHS... and other collaboratorsRecruitingYoung People With All Long-term Health ConditionsUnited Kingdom